Genmab A (GMAB) EBIT (2018 - 2026)
Genmab A (GMAB) reported EBIT of $180.0 million for Q1 2026, down 4.26% on a YoY basis from $188.0 million in Q1 2025, and down 60.78% quarter-over-quarter from $459.0 million in Q3 2025.
Genmab A (GMAB) EBIT (2018 - 2026) Analysis & Trends
Genmab A has reported EBIT for 6 years, with the latest figure at $180.0 million in Q1 2026.
- For the quarter ending Q1 2026, EBIT fell 4.26% year-over-year to $180.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 billion (up 39.65% YoY), and the FY2025 full-year result was $1.1 billion, up 9.57% from the prior year.
- EBIT for Q1 2026 stood at $180.0 million, down from $459.0 million in the prior quarter.
- The five-year high for EBIT was $459.0 million in Q3 2025, with the low at $116.0 million in Q1 2024.
- Historically, EBIT has averaged $264.1 million across 3 years, with a median of $236.0 million in 2024.
- Annual changes were most pronounced in 2025 — EBIT surged 62.07% — and 2026, when it dropped 4.26%.
- Genmab A's EBIT stood at $310.0 million in 2024, then surged by 48.06% to $459.0 million in 2025, then slumped by 60.78% to $180.0 million in 2026.
- The last three EBIT figures came in at $180.0 million (Q1 2026), $459.0 million (Q3 2025), and $360.0 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -15.76 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | -3.82 Mn |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -65.83 Mn |
| 10 | Genmab A | 48.34 Bn | 46.82 Bn | 831.00 Mn | 180.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 180.00 Mn |
| Sep 30, 2025 | 459.00 Mn |
| Jun 30, 2025 | 360.00 Mn |
| Mar 31, 2025 | 188.00 Mn |
| Sep 30, 2024 | 310.00 Mn |
| Jun 30, 2024 | 236.00 Mn |
| Mar 31, 2024 | 116.00 Mn |
| Sep 30, 2020 | 858,000.00 Bn |
| Dec 31, 2019 | 351.00 |
| Sep 30, 2019 | 0.00 |
| Dec 31, 2018 | 200.17 Mn |